Analysis Betting on hepatitis C: how financial speculation in drug development influences access to medicines BMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i3718 (Published 27 July 2016) Cite this as: BMJ 2016;354:i3718 Article Related content Metrics Responses Peer review Related articles Analysis Propaganda or the cost of innovation? Challenging the high price of new drugs Published: 11 March 2016; BMJ 352 doi:10.1136/bmj.i1284 Editorial High cost of new drugs Published: 27 July 2016; BMJ 354 doi:10.1136/bmj.i4136 Feature A pill too hard to swallow: how the NHS is limiting access to high priced drugs Published: 27 July 2016; BMJ 354 doi:10.1136/bmj.i4117 Letter Drug appraisal issues must be resolved at policy level Published: 23 August 2016; BMJ 354 doi:10.1136/bmj.i4519 Letter Compulsory licences for direct acting antiviral drugs for hepatitis C Published: 05 October 2016; BMJ 355 doi:10.1136/bmj.i5314 News Questions hang over European patent for hepatitis C drug after ruling Published: 10 October 2016; BMJ 355 doi:10.1136/bmj.i5493 Analysis Exposing drug industry funding of UK patient organisations Published: 22 May 2019; BMJ 365 doi:10.1136/bmj.l1806 EditorialHigh cost of new drugsFeatureA pill too hard to swallow: how the NHS is limiting access to high priced drugs See more Tackling poverty should have equal priority with lowering waiting lists, says King’s Fund BMJ March 18, 2024, 384 q674; DOI: https://doi.org/10.1136/bmj.q674 David Oliver: Senior medical leaders have mishandled doctors’ concerns over physician and anaesthesia associates BMJ March 15, 2024, 384 q665; DOI: https://doi.org/10.1136/bmj.q665 Doctors are told to ration salbutamol amid shortage BMJ March 15, 2024, 384 q673; DOI: https://doi.org/10.1136/bmj.q673 Tameside General Hospital must improve its maternity services, says CQC BMJ March 15, 2024, 384 q669; DOI: https://doi.org/10.1136/bmj.q669 NHS services in England are told to stop routine prescribing of puberty blockers BMJ March 14, 2024, 384 q660; DOI: https://doi.org/10.1136/bmj.q660 Cited by... Discovery and Development of Pregabalin (Lyrica): The Role of Public FundingAbstract Fulltext PDF Exposing drug industry funding of UK patient organisationsAbstract Fulltext PDF Questions hang over European patent for hepatitis C drug after rulingAbstract Fulltext PDF Compulsory licences for direct acting antiviral drugs for hepatitis CAbstract Fulltext PDF Drug appraisal issues must be resolved at policy levelAbstract Fulltext PDF High cost of new drugsAbstract Fulltext PDF